Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Powell Andrew Kenneth William Create: Alert

All | News | Filings
Date FiledTypeDescription
06/05/2023 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 15,750 options to buy @ $8.7, valued at $137k
Granted 4,660 restricted stock units @ $0
Exercised 4,507 restricted stock units @ $0
01/20/2023 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Gifted 4,000 shares @ $0
06/13/2022 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 18,000 options to buy @ $4.18, valued at $75.2k
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2021 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $28.83, valued at $432.5k
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 21,009 options to buy @ $21, valued at $441.2k
12/07/2020 3/A Powell Andrew Kenneth William (Director) has filed a Form 3/A on Silverback Therapeutics, Inc.
12/03/2020 3 Powell Andrew Kenneth William (Director) has filed a Form 3 on Silverback Therapeutics, Inc.
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2020 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.41, valued at $23.3k
Exercised 7,333 restricted stock units @ $0
06/02/2020 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\
Txns: Granted 8,303 options to buy @ $0
05/29/2020 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\
Txns: Granted 6,000 shares @ $10.99, valued at $65.9k
Exercised 6,000 restricted stock units @ $0
03/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2020 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Synthorx, Inc.
Txns: Disposed/sold 27,015 options to buy @ $14, valued at $378.2k
Disposed/sold 6,389 options to buy @ $12.4, valued at $79.2k
10/17/2019 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\
Txns: Granted 2,200 options to buy @ $0
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/30/2019 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\
Txns: Exercised 2,915 shares @ $9.91, valued at $28.9k
Exercised 2,915 restricted stock units @ $0
Granted 6,000 options to buy @ $0
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/14/2019 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on LANDEC CORP \CA\
Txns: Bought 525 shares @ $11.62, valued at $6.1k
12/21/2018 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Synthorx, Inc.
Txns: Granted 27,015 options to buy @ $14, valued at $378.2k
12/21/2018 3 Powell Andrew Kenneth William (Director) has filed a Form 3 on Synthorx, Inc.
10/22/2018 3 Powell Andrew Kenneth William (Director) has filed a Form 3 on LANDEC CORP \CA\
06/08/2018 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 8,000 options to buy @ $18.35, valued at $146.8k
05/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2017 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 8,000 options to buy @ $24.58, valued at $196.6k
01/26/2017 4 Powell Andrew Kenneth William (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
01/26/2017 3 Powell Andrew Kenneth William (Director) has filed a Form 3 on Aclaris Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy